Novo Nordisk Shares Up 4% After Promising Mid-Stage Outcomes Of Experimental Drug Amycretin Jasmine Ara Sayyed November 26, 2025
Novo Nordisk Cuts Direct-To-Consumer Prices Of Wegovy And Ozempic To $349 Per Month To Make Treatments Affordable Jasmine Ara Sayyed November 18, 2025
Novo Nordisk Cuts Growth Outlook As Competition And Policy Pressures Mount Jasmine Ara Sayyed November 5, 2025
Novo Nordisk Layoffs Dozens Of Employees At U.S. Plant Amid Global Restructuring Jasmine Ara Sayyed October 7, 2025
